Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 4
2011 1
2016 1
2018 1
2019 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
Schmitt K, Molfenter B, Laureano NK, Tawk B, Bieg M, Hostench XP, Weichenhan D, Ullrich ND, Shang V, Richter D, Stögbauer F, Schroeder L, de Bem Prunes B, Visioli F, Rados PV, Jou A, Plath M, Federspil PA, Thierauf J, Döscher J, Weissinger SE, Hoffmann TK, Wagner S, Wittekindt C, Ishaque N, Eils R, Klussmann JP, Holzinger D, Plass C, Abdollahi A, Freier K, Weichert W, Zaoui K, Hess J. Schmitt K, et al. Int J Cancer. 2019 Dec 15;145(12):3299-3310. doi: 10.1002/ijc.32481. Epub 2019 Jun 19. Int J Cancer. 2019. PMID: 31135957 Free article.
[Modern intensive care].
Heppner HJ, Schmitt K, Esslinger AS. Heppner HJ, et al. Among authors: schmitt k. Ther Umsch. 2008 Aug;65(8):455-8. doi: 10.1024/0040-5930.65.8.455. Ther Umsch. 2008. PMID: 18677697 Review. German.
[Mobility and balance].
Schmitt K, Kressig RW. Schmitt K, et al. Ther Umsch. 2008 Aug;65(8):421-6. doi: 10.1024/0040-5930.65.8.421. Ther Umsch. 2008. PMID: 18677690 Review. German.
Resistance of mitochondrial p53 to dominant inhibition.
Heyne K, Schmitt K, Mueller D, Armbruester V, Mestres P, Roemer K. Heyne K, et al. Among authors: schmitt k. Mol Cancer. 2008 Jun 12;7:54. doi: 10.1186/1476-4598-7-54. Mol Cancer. 2008. PMID: 18547443 Free PMC article.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page